Abstract
Bronchopulmonary neuroendocrine tumours (BP-NET) are a heterogeneous population of neoplasms with different pathology, clinical behaviour and prognosis compared to the more common lung cancers. The management of BP-NET patients is largely based on studies with a low level of evidence and extrapolation of data obtained from more common types of neuroendocrine tumours. This review reflects our view of the current state of the art of diagnosis and treatment of patients with BP-NET.
Original language | English |
---|---|
Journal | Acta oncologica |
Volume | 55 |
Issue number | 1 |
Pages (from-to) | 3-14 |
Number of pages | 12 |
ISSN | 0284-186X |
DOIs | |
Publication status | Published - Jan 2016 |